home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

European Antibody Congress 2006

 
  July 17, 2006  
     
 
Terrapinn Ltd, Lyon, France
4-6 December 2006


Visit http://www.lifescienceworld.com/2006/antibody/confprog.stm
 
 
Organized by: Terrapinn Ltd
Invited Speakers: Dr Jolyon White, Technology Consultant, London Technology Network
Dr Patrizia Tosetti, Scientific Officer,European Commission
Mr Philipp Hess, President and Founder, PHA Philipp Hess Associates
Dr Lincoln Tsang, Lawyer, Arnold & Porter UK LLP
Dr Richard Turner, Director of Regulatory Affairs, ERA Consulting
Mr Frank Wolpers, Industrial Sales Director, Perbio Science
Dr Christine Gebski, Senior process applications specialist, Applied Biosystems
Mr Alex Duncan, Senior Vice President of Drug Discovery, Cambridge Antibody Technology
Dr John Wijdenes, CEO and Scientific Director, Diaclone SAS
Mr Eric de la Fortelle, Global Head, F.Hoffmann-La Roche Ltd
Prof Jan Van de Winkel, Executive Vice President & CSO, Genmab
Dr Fiona Adair, CBO, Haptogen
Dr Neil Weir, Vice President, UCB Celltech
Dr Helen Findlay, Vice President, Arius Research
Dr Peter Kufer, Vice President, Micromet
Professor Laetitia Devy, Principle Scientist, Dyax SA
Professor Pauline Rudd, Professor, University Of Oxford
Dr Alain Beck, Head, Centre d'immunologie Pierre Fabre
Professor Pauline Rudd, Professor, University Of Oxford
Dr Andrew Reason, Managing Director, M-scan Ltd
Dr Neil Weir, Vice President, UCB Celltech
Dr Alain Beck, Head Centre d'immunologie Pierre Fabre
Dr Joost Kolkman, Principal Scientist, Ablynx
Dr Paul Carter, Vice President, Seattle Genetics
Professor Robert Lutz, Senior Director, Immunogen
Dr Paul Carter, Vice President, Seattle Genetics
Professor Robert Lutz, Senior Director, Immunogen
Dr Pieter De Geus, Vice President, DSM Pharmaceutical Products
Dr Gilbert Gorr, CEO and Scientific Director, Greenovation Biotech GMBH
Dr Jane Osbourn, Vice President of Discovery, Cambridge Antibody Technology
Dr Joost Kolkman, Principal Scientist, Ablynx
Dr Armin Weidmann, Director, Morphosys AG
 
Deadline for Abstracts: n/a
 
Registration: Register before 12th September and save 10%
E-mail: julie.phillips@terrapinn.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.